Sandeep A Shedage

Discovery of novel, potent and orally efficacious inhibitor of neutral amino acid transporter B0AT1 (SLC6A19).

Sanjay Kumar, D. Bandyopadhyay, Rajiv Sharma, 2021, Bioorganic & medicinal chemistry letters.

Facile synthesis, ex-vivo and in vitro screening of 3-sulfonamide derivative of 5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxylic acid piperidin-1-ylamide (SR141716) a potent CB1 receptor antagonist.

P. Mitra, Jayendra Z. Patel, Mukul R Jain, 2008, Bioorganic & medicinal chemistry letters.

Bioisosteric replacement of dihydropyrazole of 4S-(-)-3-(4-chlorophenyl)-N-methyl-N'-[(4-chlorophenyl)-sulfonyl]-4-phenyl-4,5-dihydro-1H-pyrazole-1-caboxamidine (SLV-319) a potent CB1 receptor antagonist by imidazole and oxazole.

P. Mitra, Bhupendra Mishra, Jayendra Z. Patel, 2008, Bioorganic & medicinal chemistry letters.

Identification and preclinical characterization of a novel and potent poly (ADP-ribose) polymerase (PARP) inhibitor ZYTP1

H. Patel, P. Patel, N. Srinivas, 2018, Cancer Chemotherapy and Pharmacology.

Bioisosteric replacement of dihydropyrazole of 4S-(-)-3-(4-chlorophenyl)-N-methyl-N'-[(4-chlorophenyl)-sulfonyl]-4-phenyl-4,5-dihydro-1H-pyrazole-1-caboxamidine (SLV-319) a potent CB1 receptor antagonist by imidazole and oxazole.

Bhupendra Mishra, Jayendra Z. Patel, Mukul R Jain, 2008, Bioorganic & Medicinal Chemistry Letters.